Duchenne News Tags: Astellas

Astellas Discontinues Further Screening and Enrollment for ASP0367 (MA-0211) in Pediatric Male Patients with Duchenne

Astellas discontinues screening and enrollment for ASP0367

Astellas Announces Opening of Phase 1b Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ASP0367

On Sept. 1, 2022, Astellas announced that their Phase 1b study is now open at sites across the United States. They will be adding more sites as they become ready to accept new participants.

Support Jett Foundation

Jett Foundation, Inc. is a 501(c)3 registered tax-exempt nonprofit organization. Our Federal Tax ID is 04-3563445.

Stay Connected With Us

Sign up to receive our newsletter and updates.
Required fields are denoted with an asterisk (*)

Programs

Events